About MVRx

Samantha Greene, President & Chief Executive Officer

Samantha Greene is a leader and entrepreneur with more than 20 years’ experience in the medical device and biotech arena, primarily in the cardiovascular space. She recently closed the Company’s Series B financing in the midst of the COVID-19 pandemic. The Company’s exit from stealth mode in 2015 was engineered and executed by Ms. Greene through a novel funding model. Prior to joining MVRx, Greene served in increasingly responsible leadership roles at Biosensors, Edwards and IsoStent and led 3 different first in the world clinical trials including the first consecutive patient trial in TAVR, the 1st randomized trial in DES and 1 month DAPT and conceived of and led the initiative that resulted in the first FDA single arm pivotal trial in DES. Ms. Greene has a BA in History from Union College.

Patrick Wu, Vice President, Operations

Pat Wu has over 20 years of experience in medical device R&D and operational management. His cross- functional experiences span across cardiovascular, peripheral vascular, pulmonary, GI, and ENT devices. Pat has held positions of increasing responsibility at Nitinol Devices & Components, Guidant, PneumRx (acquired by BTG), and C2 Therapeutics (acquired by HOYA/Pentax Medical). He has been instrumental in the introduction of innovative technologies and is a named inventor or co-inventor on over 40 US patents.

Pat holds a BS in Mechanical Engineering from Cal Poly, San Luis Obispo, and a MS in Engineering Management from Santa Clara University.

David Rahdert, Senior Director, Research & Development & Co-Founder

David Rahdert has over 25 years in engineering in the medical technology field with a focus on cardiovascular devices. Previously to MVRx Mr. Rahdert served in various engineering and management roles at both large and small medical device companies including Boston Scientific Corporation’s Structural Heart Division, Cordis Corporation, Pacific Consultants, IsoStent, as well as co-founding startups Ample Medical and Farallon MedSystems.

Mr. Rahdert has a Ph.D. in Mechanical Engineering and Applied Mechanics from the University of Pennsylvania, School of Engineering and Applied Science; M.S. in Bioengineering from the University of Utah School of Engineering; and B.S. in Mechanical Engineering from Duke University School of Engineering.